We previously reported on Judge Sleet’s in limine rulings directed to Section 271(f) and European Patent Office proceedings in patent litigation related to aortic valve stents between Edwards Lifesciences and Medtronic Corevalve. After a jury trial last week, the jury awarded Edwards Lifesciences lost profit damages and reasonable royalties.
The verdict form has been made public and shows that the jury found direct infringement, willful infringement, infringement pursuant to Section 271(f), and that the patents-in-suit were valid. The jury awarded $388.8 million of lost profits and $4.8 million of reasonable royalty for infringing sales not subject to lost profits.
Delaware IP Law Blog 